FDA.reportPublic FDA data

istradefylline 40 MG Oral Tablet

RxCUI
2199028
RxNorm name
istradefylline 40 MG Oral Tablet
Display name
istradefylline 40 MG Oral Tablet
Full name
istradefylline 40 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NOURIANZISTRADEFYLLINEKyowa Kirin, Inc.a7d008cb-b273-4049-a5d2-9c6902910d582025-05-20Warnings, Adverse reactionsExact identifier
rxcui: 2199028

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a7d008cb-b273-4049-a5d2-9c6902910d58istradefylline 40 MG Oral Tablet [PSN] · istradefylline 40 MG Oral Tablet [SCD]26These highlights do not include all the information needed to use NOURIANZ safely and effectively. See full prescribing information for NOURIANZ. NOURIANZ ® (istradefylline) tablets, for oral use Initial U.S. Approval: 201920250520